Drug & intervention

bromocriptine

RxCUI 1760

Clinical trials9
Recruiting0
Related conditions9
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Bromocriptine

Bromocriptine, sold under the brand name Parlodel among others, is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes. It was patented in 1968 and approved for medical use in 1975.

Read on Wikipedia ↗ Wikidata Q413581 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

9 shown
Bromocriptine for Patients With Schizophrenia and PrediabetesNCT03575000 · 2026-01-01
NOT_YET_RECRUITING
Dopamine Action on Metabolism in Relation to GenotypeNCT03525002 · 2018-05-03
COMPLETED
Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 DiabetesNCT02544321 · 2015-09-01
COMPLETED
Bromocriptine and Insulin SensitivityNCT02428946 · 2014-10-01
COMPLETED
Dopaminergic Effects on Brown Adipose TissueNCT02428933 · 2013-10-01
COMPLETED
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's DiseaseNCT01673724 · 2012-02-01
COMPLETED
The Therapeutic Effect of Bromocriptin in Patients With Primary AldosteronismNCT00451672 · 2007-01-01
UNKNOWN
Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's DiseaseNCT00240409 · 2003-07-01
COMPLETED
Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's DiseaseNCT02172573 · 1999-04-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.